Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Understand what to look for in credit card benefits to ensure you choose the best options. Maximize your rewards with informed decisions.
18,972 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
A fresh institutional stake has emerged in Victoria’s Secret stock this quarter. The $8.5 million bet suggests some m...
DraftKings posted strong top-line growth yet issued cautious guidance, sending its stock lower. This analysis breaks ...
A simple, time-tested approach often beats chasing hot sectors. Learn why a broad-market ETF could be your winning mo...
Macerich faces a retail landscape that’s evolved in 2025. This deep dive breaks down the factors shaping macerich (ma...
Oneok beat quarterly expectations but issued soft 2026 guidance, sending shares lower. This article explains why oneo...
In 2025, rare earths drew intense attention as prices and equities raced higher. The rally cooled quickly, leaving in...
Dubai is poised to test a new era of urban travel with Uber and Joby Aviation. This article breaks down what the 2026...
Navan stock down from its IPO price has dropped sharply, but a major investor just built a substantial stake. Here’s ...
A blockbuster deal reshapes the media landscape and leaves Netflix with a substantial windfall. This article breaks d...
A new Goldman Sachs analysis shows hedge funds and mutual funds loading into the same five stocks, marking a rare mom...
Microsoft's stock has faced a meaningful pullback this year. This article unpacks the factors behind the drop, evalua...